Back to company

JEMO-PHARM A/S: Financial statements 2016

CVR: 10216109

JEMO-PHARM A/S (CVR 10216109) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 8,683,000 and a net result of DKK 549,000 compared with DKK -2,892,000 the year before. Equity amounted to DKK 2,018,000. The solvency ratio was 7.1%. The company had 20,000 employees in the financial year.

Gross Profit
8,683,000 kr.
Profit/Loss
549,000 kr.
Equity
2,018,000 kr.
Total Assets
28,515,000 kr.
Employees
20,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-8.7 mio.549 t.2 mio.20000
2015---2.9 mio.1.5 mio.-
2014-3.5 mio.-5.4 mio.4.4 mio.-
2013-11.8 mio.1.5 mio.9.8 mio.-
2012-11 mio.2.1 mio.8.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is JEMO-PHARM A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

JEMO-PHARM A/S: The 2015 annual report is outApr 8, 2016

JEMO-PHARM A/S has published its annual report for 2015. The net result was DKK -2,892,000.

About JEMO-PHARM A/S

JEMO-PHARM A/S is a Danish company of the type Aktieselskab based in Stege, founded in 1986. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Mikael Andreas Mohr. The company is owned by THE WHOLE COMPANY A/S and MAM Invest ApS. The company has 27 employees. In 2025, the company reported a gross profit of DKK 11,929,000 and a net result of DKK 30,000 compared with DKK -8,629,000 the year before. Equity amounted to DKK 10,041,000.